基本信息
views: 90
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
刘江宁,男,主要从事肠道病毒、肝炎病毒的病原生物学及比较医学研究。利用手足口重要病原EV71病毒动物模型进行EV71病毒的疫苗研究以及相关药物研究;利用遗传多样性小鼠进行EV71病毒易感基因研究;开展土拨鼠WHV肝炎模型工作,建立慢性及终末期肝炎动物模型。申请国内专利2项,国际专利1项。重要代表性研究成果分别发表在Antiviral research、Phytomedicine、Vaccine等期刊上。
Research Interests
Papers共 121 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
iSciencepp.110602, (2024)
Signal Transduction and Targeted Therapyno. 1 (2024): 98-98
Na Rong,Jing Wu, Binbin Zhao,Wanjun Peng, Hekai Yang, Gengxin Zhang, Dangting Ruan,Xiaohui Wei,Jiangning Liu
ANIMAL MODELS AND EXPERIMENTAL MEDICINE (2024)
Xiaohui Wei,Jing Wu,Wanjun Peng, Xin Chen, Lihong Zhang,Na Rong, Hekai Yang, Gengxin Zhang, Gaoying Zhang, Binbin Zhao,Jiangning Liu
Vaccinesno. 6 (2024): 570
Liang Leng,Zhichao Xu,Bixia Hong,Binbin Zhao,Ya Tian, Can Wang,Lulu Yang,Zhongmei Zou,Lingyu Li, Ke Liu,Wanjun Peng,Jiangning Liu,
Nature Communicationsno. 1 (2024): 1-16
Wanjun Peng,Jing Wu, Binbin Zhao, Lihong Zhang, Xin Chen,Xiaohui Wei,Na Rong,Yunlin Han,Jiangning Liu
ANIMAL MODELS AND EXPERIMENTAL MEDICINE (2024)
Lihong Zhang,Wanjun Peng, Jing Wu,Xiaohui Wei,Na Rong, Gengxin Zhang, Hekai Yang, Xiaoyue Ding,Binbin Zhao,Jiangning Liu
Journal of virologyno. 2 (2024): e0135823-e0135823
Journal of innate immunityno. 1 (2024): 80-95
Bo Qin, Chengwei Wu,Binbin Zhao,Gang Li,Baolian Wang, Mengdie Ou,Ziheng Li,Xuli Lang, Peng Li,Jiangning Liu,Sheng Cui,Haihong Huang
Journal of medicinal chemistryno. 12 (2024): 10211-10232
Binbin Zhao, Gengxin Zhang, Jing Wu, Xiaoyue Ding,Xiaohui Wei,Wanjun Peng, Na Rong, Hekai Yang,Jiangning Liu
biorxiv(2024)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn